In vitro activity of CI-919 (AT-2266), an oral antipseudomonal compound.

We tested CI-919 (AT-2266), a nalidixic acid analog, against 555 gram-positive and gram-negative bacteria, using microbroth or agar dilution methods. The activity of CI-919 was compared with those of cephalosporins, tobramycin, ticarcillin, dicloxacillin, rifampin, chloramphenicol, ampicillin, and t...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Chartrand, S A, Scribner, R K, Weber, A H, Welch, D F, Marks, M I
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 1983
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC184783/
https://ncbi.nlm.nih.gov/pubmed/6223577
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg